๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lymphoblastic Leukemia, Acute, Childhood

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia NCT05827549Phase 210 sites๐Ÿ“ Daegu๐Ÿ“ Daejeon๐Ÿ“ Hwasun Ho Joon Im ยท Tests: Reinduction(4weeks), Cosolodation 1st(3weeks), Consolidation 2nd(3weeks), Blinatumomab 1st(High Risk Group)_4 Weeks, Blโ€ฆ Nurture by Nature Feasibility Study NCT07780123NA1 site๐Ÿ“ Frederiksberg Ina Olmer Specht ยท Tests: Nature-base intervention Pediatric Orthopaedic Implant Safety & Efficacy NCT05361980n/a1 site๐Ÿ“ Vancouver University of British Columbia ยท Tests: Pediatric orthopaedic implant Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites๐Ÿ“ Berlin๐Ÿ“ Cologne๐Ÿ“ Erlangen Miltenyi Biomedicine GmbH ยท Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia NCT03136146Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone, Etoposide Newly-diagnosed Pediatric Ph-positive B-ALL Protocol NCT07152041Phase 324 sites๐Ÿ“ Hefei๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Institute of Hematology & Blood Diseases Hospital, China ยท Tests: olverembatinib Evaluation of Pediatric eCART Implementation NCT06771830NA1 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: Pediatric eCART A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab NCT07422337n/a2 sites๐Ÿ“ Little Rock๐Ÿ“ Springdale Arkansas Children's Hospital Research Institute Ma-Spore ALL 2020 Study NCT06336395Phase 23 sites๐Ÿ“ Kuala Lumpur๐Ÿ“ Kuala Lumpur๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: Prednisolone, Dexamethasone, Vincristine, Methotrexate, L-Asparaginase Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia NCT05366218Phase 1, Phase 211 sites๐Ÿ“ Freiburg im Breisgau๐Ÿ“ Tรผbingen๐Ÿ“ Ulm University Hospital Tuebingen ยท Tests: Tafasitamab Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT NCT04746209Phase 21 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Alpha/Beta T-cell and B-cell depleted HCT, Blinatumomab International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) NCT07476729Phase 321 sites๐Ÿ“ Vienna๐Ÿ“ Ghent๐Ÿ“ Prague Charite University, Berlin, Germany ยท Tests: Inotuzumab ozogamicin (INO), Blinatumomab Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia NCT07191119NA1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Soterix tVNS device, Soterix tVNS device (sham programmed), Sleep Quality, Neurocognitive and mental health outcomes Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites๐Ÿ“ New Delhi๐Ÿ“ Puducherry University of Geneva, Switzerland CD-19 CAR-T Cell for Pediatric ALL or Lymphoma NCT06866873NA1 site๐Ÿ“ Hong Kong Hong Kong Children's Hospital ยท Tests: CAR-T Belimumab After Rituximab in Resistant Primary Juvenile SS NCT06410833Phase 41 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Rituximab, Belimumab Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians NCT06626672NA1 site๐Ÿ“ Mรผnchen Deutsches Herzzentrum Muenchen ยท Tests: Digital Health Intervention Massage Impact on Sleep in Pediatric Oncology NCT06892158NA2 sites๐Ÿ“ Washington D.C.๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Massage therapy, Standard of care Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol NCT06764238Phase 2, Phase 327 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Fuzhou Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Blinatumomab (Group A), Venetoclax (nonRand Group), Blinatumomab (Group B) Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ฮถ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) NCT03938987Phase 1, Phase 26 sites๐Ÿ“ Calgary๐Ÿ“ Calgary๐Ÿ“ Calgary University of Alberta ยท Tests: autologous CD19-directed chimeric antigen receptor (CAR) T-cells Determining the Mechanisms of Loss of CAR T Cell Persistence NCT05809284n/a3 sites๐Ÿ“ London๐Ÿ“ London๐Ÿ“ Manchester University College, London HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL NCT05495035Phase 14 sites๐Ÿ“ Hefei๐Ÿ“ Jinan๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Olverembatinib, APG-2575, Dexamethasone CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia NCT05043571Phase 11 site๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: CAR T-cell therapy Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL NCT05082519Phase 216 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ San Francisco Etan Orgel ยท Tests: IDEAL2 Intervention Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL NCT06559345Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: TMLI, TBI, Cyclophosphamide Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse NCT06649253NA3 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Rennes Rennes University Hospital ยท Tests: Sampling bone tissue and blood Study of the Medullary Microenvironment in Acute Childhood Leukemia NCT05792007NA3 sites๐Ÿ“ Tours๐Ÿ“ Tours๐Ÿ“ Tours University Hospital, Tours ยท Tests: Biological sampling in patients, Biological sampling in control patients Multicenter HomeVENT: Home Values and Experiences Navigation Track NCT06102330NA4 sites๐Ÿ“ Tampa๐Ÿ“ New Orleans๐Ÿ“ Baltimore Johns Hopkins University ยท Tests: HomeVENT decision support tool
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy